Kadmon Holdings Inc KDMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:54 PM EDT
8.79quote price arrow down-0.03 (-0.34%)
Volume
1,139,984
Close
8.82quote price arrow up+0.02 (+0.23%)
Volume
3,898,264
52 week range
3.15 - 9.20
Loading...
  • Open8.80
  • Day High8.89
  • Day Low8.74
  • Prev Close8.80
  • 52 Week High9.20
  • 52 Week High Date09/08/21
  • 52 Week Low3.15
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap1.529B
  • Shares Out173.33M
  • 10 Day Average Volume26.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change112.53

KEY STATS

  • Open8.80
  • Day High8.89
  • Day Low8.74
  • Prev Close8.80
  • 52 Week High9.20
  • 52 Week High Date09/08/21
  • 52 Week Low3.15
  • 52 Week Low Date11/02/20
  • Market Cap1.529B
  • Shares Out173.33M
  • 10 Day Average Volume26.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change112.53

RATIOS/PROFITABILITY

  • EPS (TTM)-0.67
  • P/E (TTM)-13.25
  • Fwd P/E (NTM)-11.95
  • EBITDA (MRQ)-117.225M
  • ROE (MRQ)-210.70%
  • Revenue (MRQ)1.87M
  • Gross Margin (MRQ)61.82%
  • Net Margin (MRQ)-5,961.77%
  • Debt To Equity (MRQ)696.07%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kadmon Holdings Inc

There is no recent news for this security.

Profile

MORE
Kadmon Holdings, Inc. is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak...
Tasos Konidaris
Non-Executive Chairman
Harlan Waksal M.D.
President
Steven Meehan
Chief Financial Officer
Gregory Moss Esq.
Executive Vice President
John Ryan M.D., Ph.D.
Executive Vice President
Address
450 E 29th St
New York, NY
10016
United States

Top Peers

SYMBOLLASTCHG%CHG
PRLD
Prelude Therapeutics Inc
34.22+0.22+0.65%
GBIO
Generation Bio Co
27.18+0.58+2.18%
REPL
Replimune Group Inc
32.64+1.38+4.41%
CMPS
Compass Pathways PLC
33.36+0.81+2.49%
INO
Inovio Pharmaceuticals Inc
7.75+0.18+2.38%